cubist pharmaceuticals american biopharmaceutical company targeted pathogens like mrsa company employed people mostly lexington december merck co acquired cubist per share cash cubist founded may john k clarke paul r schimmel phd barry bloom phd also cubist appeared fortune list fastest growing companies named deloitte technology fast company acquired adolor maker drug treatment company expected sales drug cubicin grow billion dollars per year july cubist pharmaceuticals agreed purchase trius therapeutics optimer pharmaceuticals around succeeding michael bonney president robert j perez announced take leadership january january cubist pharmaceuticals became wholly owned subsidiary merck co company developed cubicin daptomycin injection first antibiotic class antiinfectives called lipopeptides cubist settled patent litigation teva pharmaceutical industries regarding april reached deal optimer pharmaceuticals class bacterium fighting drugs co marketed optimers fidaxomicindificid million per product pipeline focused gramnegative bacterial clostridium difficileassociated respiratory syncytial tedizolid approved us food drug administration june httpsenwikipediaorgwikicubistpharmaceuticals